NATCOPHARMNSENatco Pharma Limited· PharmaceuticalsLowNeutral
Announced Thu, 21 May · 12:28 IST

Natco Pharma Limited has informed the Exchange about Schedule of meet

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.1%1-day move
₹1157.00
prior close
₹1163.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+0.7+0.8+0.7+1.1+1.8+2.7+1.9-13.1-18.6-25.3-23.7-16.9
Up moveDown movePending
AI summary

Natco Pharma Limited has announced an earnings call with investors and analysts scheduled for Friday, May 29, 2026 at 16:30 PM IST. The call will discuss the company's audited financial results for the quarter and year ended March 31, 2026. Key management personnel including Vice-chairman and CEO Rajeev Nannapaneni, Executive VP Rajesh Chebiyam, and CFO Amit Parekh will participate. The conference is hosted by 360 ONE Capital Market Private Limited with dial-in details provided for domestic and international participants.

Likely market impact

This is a routine scheduling announcement informing shareholders about an upcoming earnings discussion. No direct impact on stock price, but investors should note the date to participate or review the call outcomes.